We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Valirx Plc | LSE:VAL | London | Ordinary Share | GB00BLH13C52 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.05 | -1.61% | 3.05 | 3.00 | 3.10 | 3.15 | 3.05 | 3.10 | 1,785,708 | 13:41:03 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Medical Laboratories | 0 | -2.37M | -0.0262 | -1.16 | 2.75M |
Date | Subject | Author | Discuss |
---|---|---|---|
23/1/2023 15:08 | Someone mentioned 2 weeks ago this would not fall below 12p . | francoismyname | |
23/1/2023 14:38 | Theorem has done real damage to Suzanne Dilly's credibility..I sympathise ..hope for a better future for val. | baldrick1 | |
21/1/2023 08:53 | Here's another VC site so the timescale VAL are within with THX is pretty normal:https://www.i | wulber | |
21/1/2023 08:40 | Who is to doubt Suzy and why on earth would she lie and damage her position, livelihood and reputation?https://v | wulber | |
21/1/2023 01:14 | Wulber TRx has been 'on' according to SD since Nov 2021. | carlisle44 | |
20/1/2023 23:38 | Nice bullish candle there stig and Macd turning up too..... | wulber | |
20/1/2023 23:17 | THX couldn't raise z flag never mind the credit they need. Have you been living under a rock!! | tburns | |
20/1/2023 21:36 | Lots of assumptions there Porky and you could be miles out. THX still on according to SD plus, what else could THX handle with the legacy assets plus the 201 other handles? Again with the lab, we have no idea behind closed doors what is going on at this juncture and there could be nice cash flow sooner than we think! GLA | wulber | |
20/1/2023 11:23 | Fair play Porky. You summed up everything that is wrong with VAL, how were go there, where we are likely to go in the shirt term and what Dilly needs to do to rectify the problem. You did that in 10 paragraphs, please send it to here as would take her 10 weeks to come to the same assessment, if she had the business acumen to do so. | tburns | |
20/1/2023 09:22 | How can he when he’s on strike as a postman obviously is the hours that he posts ha. | 412069 | |
20/1/2023 09:13 | You should run the company..you got all the solutions..why not? ;) | baldrick1 | |
20/1/2023 05:13 | Buying spree, you must be kidding - Have you read the CENKOS report? The company has ZERO focus on revenue it only knows how to spend hence why it wants resolution 4 passed by shareholders now to give it an open mandate to issue another 30m of shares at anytime it wants to for further cash. As it stands as expected their cash burn increased by 210k last year. With this raise they will have enough cash runway to circa April 2024. This is a positive. The business plan has changed yet again, they not only want to set one lab up to do own and third party work (no lab revenues forecast for 2023) they want to acquire others. This will be costly and further raises will be required for that so expect more dilution. They have identified 4 targets yet no experience of running one lab profitably let alone 4. To set up lab 1 they forecast 400k for equipment and other one off costs and 200k of running costs to the end of this year for rent and a lab manager and assistant. There is nothing in the CENKOS report detailed for sales and marketing so not sure how they will tender for contracts. They forecast no revenue this year BUT it will save some money bringing current outsourced work inhouse. Lab running costs going forward will be 300k. CENKOS state the lab will likely be in Medicity Nottingham and they will have lots of business contacts nearby. I think its totally naive to think lab contracts will just land on them - they will need to win contracts in a competitive space and that will require good sales and marketing imo. Should the THX deal land Q1 before end of March 23 this would give them a further £1.3m in 2023 year resulting in extending the cash runway through to end of 2024. IMO the risk profile has gone up materially. My price target is now 5p by June. After the results for 22 are out April 23? IF the THX deal is NOT sorted by then I think the share price will materially fall knowing that a further discounted placing will be on its way. Suzy was right to do this small raise now on the authority they currently have from shareholders and push for a new resolution at the AGM because if she didn't it would be at a materially discounted level. When i say she was right, i mean from the perspective of protecting the business and not leaving until the eleventh hour, not what is best for shareholders. Where this has all gone wrong imo is giving their prime asset 201 away to a skint start up that cant raise cash. Making it exclusive and then when timelines missed rather than pull the exclusive issued and start looking for an alternative partner they extend exclusivity on an indefinite basis. Further because they have no focus on revenue (cash raises are too easy)they don't even collect the monthly support fees from them. We will see how this unfolds going forward, those adding at 11p i think would be wise to flip on any spikes especially if THX comes across the line. Otherwise its dilution all the way imo. One factor that could change fortunes is if they can win decent sized new lab contracts that pay or they can monetise 301 or kings but i don't see that in 2023 i think its far too soon, looking at late 24/25 earliest imo. This rests now on 201 being done to extend the cash runway otherwise they have no way of gaining decent revenue other than to squeeze shareholders for more - jury is out. Finally, one other scenario that could turn this around, get Kevin out and the NED Martin Lampshire (does he add any value?) replace with Adam. Demote Suzy to head sciences. Bring in another NED that will invest and show some commercial acumen and support Adam. Get Stella to put her hand in her pocket and buy shares. Good Luck | porky9 | |
19/1/2023 18:59 | Guess its good as why would their broker send out anything else. Bottom found l hope and held up well - now need the meat on the bones to propel the share price back up - expect a buying spree asap. | wulber | |
19/1/2023 08:35 | What is the content of the report good or bad? | baldrick1 | |
19/1/2023 08:13 | Cenkos just released latest research note on valirx | jasonpugh | |
18/1/2023 09:44 | 01. 👌 | jasonpugh | |
17/1/2023 22:33 | 201 👌 | jasonpugh | |
17/1/2023 19:51 | 01👌 | jasonpugh | |
16/1/2023 11:40 | Lab sorted, the next carrots going to be 301 kings or 201 take you pick. Or 4p Franco’s | 412069 | |
14/1/2023 21:59 | Yeah, but what a great decision and purchase - look at the medium term new income! Plus money in the bank. | wulber | |
14/1/2023 18:44 | For those saying we have only dropped a penny with this fundraise, you're fooling yourselves. It's the reason we have gone from 18p to 11p. Those who knew this was coming have been selling down happy in the knowledge Dilly was planning another funding exercise. No wonder she turns a funny shade of scarlet on all those zoom calls. I'm beginning to think this is just another AIM lifestyle company. She's a rubbish CEO making a living on shareholders backs. | sooty snipes | |
14/1/2023 13:26 | I think it tells you the commitments we're already in the bag. | paddyfool |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions